Phio Pharmaceuticals Corp.
PHIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $2 | $5 | $13 |
| - Cash | $5 | $8 | $12 | $24 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9 | -$7 | -$7 | -$11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$4 | -$6 | -$7 | -$9 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$11 | -$11 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$11 | -$11 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.91 | -46.76 | -89.61 | -111.32 |
| % Growth | 98.1% | 47.8% | 19.5% | – |
| Operating Cash Flow | -$7 | -$11 | -$12 | -$12 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$7 | -$11 | -$12 | -$12 |